(Q48351969)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Richard Mailman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

G E Duncan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

J A Lieberman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

65-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

Observations on the psychotomimetic effects of Sernyl.

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

7 January 2021

Dissociative Anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Brain activity patterns: assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Dextroamphetamine. Evaluation of psychomimetic properties in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Functional and anatomical aspects of prefrontal pathology in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Clozapine improves dizocilpine-induced delayed alteration impairment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

MK-801-induced neuronal damage in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Provocative tests with psychostimulant drugs in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Neuroanatomical characterization of inferior collicular seizure genesis: 2-deoxyglucose and stimulation mapping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The dopamine hypothesis of schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Neuropsychological correlates of syndromes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

Drugs, neurotransmitters, and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900926-3

10.1016/S0006-8993(98)00926-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9813244%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference